COVID-19 Saliva Screening Test Potential Market Trends, Surging Demand, Detailed Analysis, And Forecast To 2033

"The new report published by The Business Research Company, titled ""COVID-19 Saliva Screening Test Potential Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the COVID-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.57 billion in 2023 to $3.90 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16026&type=smp

The Role Of Increasing Healthcare Expenditure In Driving The Growth Of The COVID-19 Saliva Screening Test Market
The increasing healthcare expenditure is expected to propel the growth of the COVID-19 saliva screening test potential market going forward. Healthcare expenditure is the entire amount spent on healthcare-related goods and services, including prescription drugs, hospital stays, doctor visits, medical equipment, and public health campaigns. The healthcare expenditure is increasing due to several factors, such as minimally invasive surgeries, cutting-edge diagnostic tools, increase in research and development for new drugs, utilization of healthcare services, and specialty medications. The higher healthcare expenditure can provide the necessary resources and support to leverage the full potential of COVID-19 saliva screening tests, contributing to more effective pandemic management and better public health outcomes. For instance, in May 2023, according to the Office for National Statistics, a UK-based statistics authority, the UK's healthcare expenditure grew by 9.7% in real terms and 9.4% in nominal terms. The overall amount spent on healthcare in the UK in 2021 was $367.25 billion (£280.7 billion), while the total amount spent on pharmaceuticals was $51.84 billion (£39.6 billion). Further, spending on preventative care more than quadrupled to $45.93 billion (£35.1 billion) in 2021 compared to the previous year. Therefore, the increasing healthcare expenditure is driving the growth of the COVID-19 saliva screening test potential market.

Innovative Technologies And Advanced Laboratory Techniques Driving Growth In The COVID-19 Saliva Screening Test Market
Major companies operating in the COVID-19 saliva screening test potential market are focused on developing innovative programs, such as COVID-19 saliva testing programs, to expand their product offerings and reach a broader customer base. A COVID-19 saliva testing program is an initiative or system implemented to test for SARS-CoV-2 (the virus that causes COVID-19) using saliva samples rather than more invasive nasopharyngeal or nasal swab samples. For instance, in April 2021, Mount Sinai Health System, a US-based healthcare network, launched the Mount Sinai COVID-19 PCR Saliva Testing program to provide quick, noninvasive, and precise testing. This testing program is designed to provide quick and accurate results, enabling individuals to return to in-person work settings and leisure activities confidently. The program's scalability is noteworthy, with plans to process up to 100,000 daily tests, ensuring widespread testing availability. Its success is further highlighted by the ability to report results within 24 hours for most tests, demonstrating efficiency and rapid response capabilities. The program aims to facilitate the safe return to in-person learning and activities by offering child-friendly and comfortable testing options. This initiative emphasizes the importance of testing in controlling the spread of COVID-19 and supports the community's well-being during the reopening phase.

The COVID-19 saliva screening test potential market covered in this report is segmented -

1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode of Testing: Centralized Testing, Decentralized Testing

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16026&type=discount

Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.

Contents of the report:
1. Executive Summary
2. COVID-19 Saliva Screening Test Potential Market Report Structure
3. COVID-19 Saliva Screening Test Potential Market Trends And Strategies
4. COVID-19 Saliva Screening Test Potential Market - Macro Economic Scenario
5. COVID-19 Saliva Screening Test Potential Market Size And Growth
…..
27. COVID-19 Saliva Screening Test Potential Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.